Star Lake Bioscience Co (SHSE:600866) Net Income From Continuing Operations : ¥817 Mil (TTM As of Mar. 2024)

View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co Net Income From Continuing Operations?

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. Star Lake Bioscience Co's net income from continuing operations for the three months ended in Mar. 2024 was ¥253 Mil. Its net income from continuing operations for the trailing twelve months (TTM) ended in Mar. 2024 was ¥817 Mil.

Star Lake Bioscience Co Net Income From Continuing Operations Historical Data

The historical data trend for Star Lake Bioscience Co's Net Income From Continuing Operations can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co Net Income From Continuing Operations Chart

Star Lake Bioscience Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Net Income From Continuing Operations

Get a 7-Day Free Trial

149.55

148.71

249.08

1,182.99

685.70

Star Lake Bioscience Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Income From Continuing Operations	Get a 7-Day Free Trial															122.02	110.85	262.04	190.79	253.49

Star Lake Bioscience Co Net Income From Continuing Operations Calculation

Net Income From Continuing Operations indicates the net income that a firm brings in from ongoing business activities. These activities are expected to continue into the next reporting period. It excludes extraordinary items, income from the cumulative effects of accounting changes, non-recurring items, income from tax loss carry forward, and preferred dividends.

Net Income From Continuing Operations for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥817 Mil.

Star Lake Bioscience Co (SHSE:600866) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Net Income From Continuing Operations

Traded in Other Exchanges

N/A

Address

No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060

Website

http://www.starlake.com.cn

Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.

Executives

Chen Wu	Director
Liu Xian Yi	Director
Liao Jie Ming	senior management
Chen Chao Ju	Director
Li Qing Lin	Supervisors
Zhong Zi Rong	Director

Star Lake Bioscience Co (SHSE:600866) Headlines

No Headlines